Equillium Names Chief Business Officer Bruce Steel as Successor CEO

Equillium (NASDAQ: [[ticker:EQ]]) announced this week that CEO Dan Bradbury would step down from the role Jan. 1 and be succeeded by Bruce Steel, the company’s current chief business officer and president. Bradbury will remain executive chairman. Steel, a co-founder of the company, was previously the founder and managing director of BioMed Realty’s strategic investment arm.

La Jolla, CA-based Equillium, which is advancing a drug called itolizumab as a treatment for immuno-inflammatory disorders, also said it was promoting Christine Zedelmayer from vice president of operations to senior vice president and chief operating officer.

Author: Sarah de Crescenzo

Sarah is Xconomy's San Diego-based editor. Prior to joining the team in 2018, she wrote about startups, tech and finance at the San Diego Business Journal. Her decade of full-time news experience includes coverage of subjects including campaign finance, crime and courts as a reporter and editor at outlets throughout California, including the Orange County Register. She earned a bachelor's degree in English Literature at UC San Diego, where she wrote for the student newspaper and played collegiate lacrosse. In 2019, she earned an MBA at UC Irvine. View all posts by Sarah de Crescenzo